KLK3 and posterior cortical atrophy: While primary PCA can be potentially cured, the high rate of overtreatment highlights the limitations of current diagnostic tools, such as prostate-specific antigen (PSA) and grading according to the International Society of Urological Pathology (ISUP), in accurately discriminating between indolent and aggressive cases [2].